Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v4-FR
Language English French
Date Updated 2020-04-08 2020-02-06
Drug Identification Number 02231460 02231460
Brand name MAVIK MAVIK
Common or Proper name TRANDOLAPRIL TRANDOLAPRIL
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients TRANDOLAPRIL TRANDOLAPRIL
Strength(s) 2MG 2MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100BT 100BT
ATC code C09AA C09AA
ATC description ACE INHIBITORS, PLAIN ACE INHIBITORS, PLAIN
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-02-15 2020-02-15
Actual start date 2020-02-07
Estimated end date 2020-04-07 2020-03-01
Actual end date 2020-04-07
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments